Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Shenghuang Ketong Cream is a topical Traditional Chinese Medicine (TCM) hospital preparation developed by the Beijing Hospital of Traditional Chinese Medicine. It is specifically formulated for the treatment of herpes zoster (shingles) and the management of associated acute pain and post-herpetic neuralgia (PHN). The cream's therapeutic action is based on TCM principles of clearing heat, resolving toxins, and activating blood circulation to alleviate pain. As a hospital preparation (院内制剂) in China, it is approved for clinical use and distribution within the developing institution's medical network. It is widely utilized for its ability to reduce inflammation and provide symptomatic relief for the characteristic burning and stabbing pain caused by the varicella-zoster virus.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Shenghuang Ketong Cream.